Saturday 17 October 2026
Export CTXR’s income statement to Excel — free account
Citius Pharmaceuticals, Inc.
CTXR Healthcare Biotechnology
In the quarter to June 2026, EPS grew 57.5% and free cash flow fell 60.5%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.46
0.00
0.00%
Follow CTXR
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.17 | 1.39 | 3.16 | 1.72 | 3.41 | 18.28 | 9.84 | 5.95 | 0.40 | 0.62 |
Net Debt/EBITDA |
0.04 | 0.32 | 0.67 | 0.51 | 0.78 | 3.00 | 1.26 | 0.72 | 0.08 | 0.11 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.71 | 0.77 | 0.90 | 0.80 | 0.96 | 0.99 | 0.84 | 0.86 | 0.70 | 0.71 |
Capex/Depreciation |
0.00 | (0.81) | 0.00 | 0.00 | (0.01) | (0.04) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(827.70) | (11.74) | (872.73) | (951.12) | (1,128.07) | (2,178.88) | (132.52) | (31.14) | — | (143.86) |
| (102.85%) | (53.65%) | (50.33%) | (56.57%) | (57.70%) | (29.44%) | (28.48%) | (34.58%) | (48.55%) | (49.38%) | |
| (73.12%) | (44.79%) | (45.20%) | (45.91%) | (43.59%) | (26.32%) | (26.24%) | (30.97%) | (36.49%) | (30.24%) | |
ROIC |
(28.27%) | (33.30%) | (46.13%) | (50.62%) | (55.41%) | (23.45%) | (33.74%) | (35.35%) | (37.05%) | (32.86%) |
Return on Tangible Assets |
193.49% | (1,083.58%) | (182.30%) | (466.66%) | (177.50%) | (35.60%) | (84.02%) | (117.84%) | 186.10% | 220.46% |
Average Days of Receivables |
— | — | 0.00 | — | — | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.05 | 0.25 | 0.21 | 0.07 | 0.08 | 0.09 | 0.08 | 0.07 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(40.72) | (36.36) | (26.36) | (15.42) | (10.81) | (5.58) | (4.85) | (4.80) | (4.19) | (2.40) |
Cash per Share |
2.03 | 14.61 | 21.39 | 9.79 | 8.85 | 16.13 | 7.14 | 4.38 | 0.48 | 0.38 |
Shareholders Equity per Share |
115.71 | 100.08 | 64.91 | 33.67 | 21.49 | 30.57 | 17.70 | 15.11 | 11.02 | 7.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
115.71 | 100.08 | 64.91 | 33.67 | 21.49 | 30.57 | 17.70 | 15.11 | 11.02 | 7.01 |
Free Cash Flow |
(5.90) | (7.97) | (11.32) | (12.44) | (16.93) | (24.26) | (28.36) | (29.06) | (28.20) | (26.55) |
Working Capital |
(4.29) | 0.96 | 6.88 | 3.33 | 9.88 | 68.83 | 40.03 | 28.59 | (21.59) | (16.98) |
Capital Expenditures |
— | 0.00 | — | — | 0.00 | (0.01) | — | — | — | — |
Net Current Asset Value |
(4.29) | 0.96 | 6.88 | (1.65) | 3.88 | 63.17 | 33.99 | 22.19 | (28.33) | (25.48) |
| Other line items | ||||||||||
Quick Ratio |
0.06 | 1.30 | 3.14 | 1.71 | 3.38 | 17.60 | 9.21 | 4.58 | 0.09 | 0.09 |
Depreciation/Fixed assets |
0.35 | 0.81 | 1.20 | 1.50 | 95.25 | 23.56 | 43.83 | 138.79 | 0.00 | 0.00 |
Cash ROIC |
(34.58%) | (31.70%) | (30.55%) | (35.49%) | (35.50%) | (11.96%) | (19.54%) | (24.65%) | (36.46%) | (32.47%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(40.72) | (36.35) | (26.36) | (15.42) | (10.81) | (5.58) | (4.85) | (4.80) | (4.19) | (2.40) |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.73 | 0.76 | 1.09 | 2.14 | 2.28 | 1.57 | 1.22 | 2.05 | 3.93 | 9.31 |
Average Inventory |
— | — | — | — | — | — | — | — | — | 15.28 |
Average Assets |
11.35 | 23.18 | 27.73 | 33.90 | 40.26 | 93.10 | 128.21 | 108.81 | 110.13 | 123.79 |
Average Common Equity |
8.07 | 19.36 | 24.91 | 27.51 | 30.41 | 83.23 | 118.10 | 97.43 | 82.77 | 75.81 |
Capex to Sales |
— | 0.00 | — | — | 0.00 | 0.00 | — | — | — | — |
Columns are period end dates